Michael Ferraresso - 10 Mar 2021 Form 3/A - Amendment Insider Report for AVEO PHARMACEUTICALS, INC.

Role
Chief Commercial Officer
Signature
/s/ Danielle V. Holland, attorney-in-fact
Issuer symbol
N/A
Transactions as of
10 Mar 2021
Net transactions value
$0
Form type
3/A - Amendment
Filing time
13 May 2022, 15:51:39 UTC
Date Of Original Report
24 Mar 2021
Next filing
11 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AVEO Common Stock 917 10 Mar 2021 By Spouse F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were inadvertently omitted from the original Form 3 filed by the reporting person and also were omitted from one Form 4 filed by the reporting person after his original Form 3 was filed.